glp-1 agonists for obesity receptor – How weight loss injections work Pharmacological interventions for obesity in

In ex-vivo models with rat and porcine lenses, NPI-002 inhibited oxidative-induced cataracts

Harding D, Fournel-Gigleux S, Jackson MR, Burchell B

Epigenetic Modulation / Chromatin Remodeling Research using spectroscopic and molecular modeling analyses indicates Epitalon interacts with core histone proteins and chromatin-associated complexes, influencing DNA methylation patterns and heterochromatin organization

3 Evolution of GLP-1-based therapeutics 3.1 First-generation GLP-1RAs The development of GLP-1 receptor agonists stemmed from the significant finding that natural GLP-1 had an exceptionally short half-life of about 1.5 to 5 min, due to its rapid degradation by the enzyme DPP-4 (Campbell and Drucker 2013) (Fig

Role of the gut microbiome in chronic diseases: A narrative review